INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
Corporate insider
OS

Olsson Shawn

Chief Commercial OfficerCIK 0002015796

EDGAR filingsOpen in network
Disclosed transactions6
Buys / sells0 / 2
Max Insider Score20
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
OS
Olsson ShawnChief Commercial Officer
LENZLENZ Therapeutics, Inc.
Grant or award
A—
84.2K sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    LENZ Therapeutics, Inc.Chief Commercial Officer · Nov 19, 2025
5
OS
Olsson ShawnChief Commercial Officer
LENZLENZ Therapeutics, Inc.
Grant or award
A
—
14.0K sh
Jan 2, 2026
Jan 6, 2026
traded Jan 2, 2026
+4d
SEC FORM 4

Evidence

11
OS
Olsson ShawnChief Commercial Officer
LENZLENZ Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$21K
10.0K sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC FORM 4

Evidence

16
OS
Olsson ShawnChief Commercial Officer
LENZLENZ Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$108K
4,212 sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC FORM 4

Evidence

20
OS
Olsson ShawnChief Commercial Officer
LENZLENZ Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$153K
5,788 sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC FORM 4

Evidence

7
OS
Olsson ShawnChief Commercial Officer
LENZLENZ Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
10.0K sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC FORM 4

Evidence